Patents by Inventor Ying Ying Yiu

Ying Ying Yiu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220120731
    Abstract: Prolonged exposure of CD8+ T cells to antigenic stimulation leads to a state of diminished function, termed exhaustion; during exhaustion there is a subset of functional CD8+ T cells defined by surface expression of SIRP(alpha) protein. On SIRP+ CD8+ T cells, expression of coinhibitmy receptors is counterbalanced by expression of co-stimulatory receptors and it is only these SIRP+ cells that actively proliferate, transcribe IFNg and show cytolytic activity. Therapeutic blockade of PD-L1 or other inhibitory receptors to reinvigorate exhausted CD8+ T cells expands the cytotoxic subset of SIRP+ CD8+ T cells.
    Type: Application
    Filed: January 30, 2020
    Publication date: April 21, 2022
    Inventors: Michal Caspi Tal, Lara Myers, Kim J. HasenKrug, Ying Ying Yiu, Irving L. Weissman
  • Publication number: 20220091104
    Abstract: Methods and kits are provided for determining whether an individual is responsive to therapeutic CD47 blockade. Specifically, the disclosure provides methods of determining whether a cell or cell population is responsive to therapeutic CD47 blockade, the method comprising: assaying a cell sample from an individual to determine (a) the level of expression of signal regulatory protein alpha (SIRPalpha) on phagocytic immune cells, or (b) the genotype of the individual at a nucleotide polymorphism (SNP) associated with SIRPalpha expression. Further disclosed are SNPs associated with SIRPalpha expression.
    Type: Application
    Filed: September 11, 2019
    Publication date: March 24, 2022
    Inventors: Ying Ying Yiu, Michal Caspi Tal, Amira Barkal, Hanna Maria Ollila, Irving L. Weissman